Product image of Medrol (Methylprednisolone) supplied by GNH India

Medrol

Active Ingredient:
Methylprednisolone
Origin:
EU

Medrol (Methylprednisolone)

Methylprednisolone, the active ingredient in Medrol, is a synthetic glucocorticoid presented as an oral dosage form for systemic administration. It exerts anti‑inflammatory and immunosuppressive effects and is prescribed for allergic disorders, asthma or COPD exacerbations, rheumatic diseases such as rheumatoid arthritis, and severe dermatologic conditions. It is used in both adult and pediatric patients when clinically indicated.

GNH India supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with reliable quality assurance and regulatory compliance across EU and global markets.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Methylprednisolone acts as a systemic glucocorticoid to modulate inflammatory and immune pathways.
  • Allergic disorders: reduces inflammation and symptom severity in conditions such as allergic rhinitis and urticaria.
  • Asthma and COPD exacerbations: improves airflow and decreases airway inflammation during acute attacks.
  • Rheumatic diseases: alleviates joint pain and swelling in rheumatoid arthritis and related conditions.
  • Dermatologic conditions: controls severe eczema, psoriasis and other inflammatory skin disorders.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interacts with glucocorticoid response elements on DNA. This regulates transcription of anti‑inflammatory genes while suppressing pro‑inflammatory cytokines, chemokines, and adhesion molecules, thereby decreasing leukocyte migration and stabilizing lysosomal membranes.

Side Effects

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Increased appetite: heightened hunger and possible weight gain.
  • Insomnia: difficulty falling or staying asleep.
  • Elevated blood glucose: transient rise in blood sugar levels.
  • Mild gastrointestinal discomfort: nausea or stomach upset.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production, risk of adrenal crisis on abrupt discontinuation.
  • Severe infection: heightened susceptibility to bacterial, viral or fungal infections.
  • Osteonecrosis: bone tissue death, particularly in weight‑bearing joints.

Precautions & Warnings

  • When prescribing methylprednisolone, clinicians should consider several precautionary measures to minimize risks.
  • Assess infection risk: evaluate for active or latent infections before initiating therapy.
  • Monitor blood glucose: patients with diabetes may require dose adjustments.
  • Screen for osteoporosis: long‑term use warrants bone density assessment.
  • Avoid abrupt discontinuation: taper the dose to prevent adrenal insufficiency.
  • Use lowest effective dose: limit exposure to reduce side‑effect burden.
  • Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Avoid Interactions

Methylprednisolone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, phenytoin): may markedly reduce corticosteroid levels.
  • Live vaccines: increased risk of disseminated infection due to immunosuppression.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration.
  • Anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring.
  • Diabetes medications: corticosteroid‑induced hyperglycemia may necessitate dose adjustment.

Frequently Asked Questions

Medrol contains methylprednisolone, a glucocorticoid that is prescribed to treat a variety of inflammatory and immune‑mediated conditions, including allergic disorders, asthma or COPD flare‑ups, rheumatoid arthritis, and severe skin diseases such as eczema or psoriasis.

Methylprednisolone binds to intracellular glucocorticoid receptors, and the resulting complex alters gene transcription. It increases the production of anti‑inflammatory proteins while suppressing genes that code for pro‑inflammatory cytokines, thereby reducing inflammation and immune activity.

The appropriate dose of Medrol is determined by the prescribing clinician based on the specific indication, severity of disease, patient age, weight and comorbidities. Dosage regimens can vary widely, so patients should follow the exact instructions provided by their healthcare professional.

Safety data for methylprednisolone in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Physicians will assess individual circumstances before prescribing.

To request Medrol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Medrol (methylprednisolone) is a medium‑potency glucocorticoid, generally considered more potent than prednisolone but less potent than dexamethasone. It offers a favorable balance of anti‑inflammatory strength and duration of action, making it suitable for acute exacerbations where rapid control is needed.

Medrol should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Medrol is taken orally, usually as a tablet or liquid, and should be swallowed with water. The exact administration schedule—such as once daily or divided doses—depends on the prescribing doctor’s instructions and the condition being treated.

Serious risks include adrenal suppression, which can lead to adrenal crisis if the drug is stopped abruptly; increased susceptibility to severe infections; and rare complications such as osteonecrosis of bone. Patients should be monitored closely for these events.

Medrol is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, those with systemic fungal infections, and individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe hypertension, or active peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT